experts speculate that the natural expiration of the early adopter wave and growing privacy concerns are to blame. But companies might be able to recover if they provide compelling medical reasons for users to get the tests.
from Tech https://ift.tt/2Zndhpa
from Tech https://ift.tt/2Zndhpa